Literature DB >> 17906120

Candida albicans drug resistance another way to cope with stress.

Richard D Cannon1, Erwin Lamping1, Ann R Holmes1, Kyoko Niimi1, Koichi Tanabe2, Masakazu Niimi2, Brian C Monk1.   

Abstract

There are relatively few classes of antifungal drugs. This restricts clinicians' therapeutic choices and these choices are further reduced by the emergence of drug resistance. Exposure to antifungal drugs represents an environmental stress for the fungal pathogen Candida albicans. The immediate response of C. albicans to antifungals may be drug tolerance, which can lead to drug resistance. This article examines C. albicans drug resistance from the perspective of it being a stress response and investigates how commonality with other stress-response pathways gives insights into the prospects for overcoming, or preventing, drug resistance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17906120     DOI: 10.1099/mic.0.2007/010405-0

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  69 in total

Review 1.  Milestones in Candida albicans gene manipulation.

Authors:  Dhanushki P Samaranayake; Steven D Hanes
Journal:  Fungal Genet Biol       Date:  2011-04-14       Impact factor: 3.495

2.  Amphotericin primarily kills yeast by simply binding ergosterol.

Authors:  Kaitlyn C Gray; Daniel S Palacios; Ian Dailey; Matthew M Endo; Brice E Uno; Brandon C Wilcock; Martin D Burke
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

3.  A Combination Fluorescence Assay Demonstrates Increased Efflux Pump Activity as a Resistance Mechanism in Azole-Resistant Vaginal Candida albicans Isolates.

Authors:  Somanon Bhattacharya; Jack D Sobel; Theodore C White
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

Review 4.  Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance.

Authors:  Leah E Cowen; William J Steinbach
Journal:  Eukaryot Cell       Date:  2008-03-28

5.  Photodynamic antimicrobial chemotherapy (PACT) inhibits biofilm formation by Candida albicans, increasing both ROS production and membrane permeability.

Authors:  Isabela Bueno Rosseti; Luciene Reginato Chagas; Maricilia Silva Costa
Journal:  Lasers Med Sci       Date:  2013-11-01       Impact factor: 3.161

6.  Candida albicans flu1-mediated efflux of salivary histatin 5 reduces its cytosolic concentration and fungicidal activity.

Authors:  Rui Li; Rohitashw Kumar; Swetha Tati; Sumant Puri; Mira Edgerton
Journal:  Antimicrob Agents Chemother       Date:  2013-02-04       Impact factor: 5.191

7.  A small molecule inhibitor of fungal histone acetyltransferase Rtt109.

Authors:  Jessica Lopes da Rosa; Vineeta Bajaj; James Spoonamore; Paul D Kaufman
Journal:  Bioorg Med Chem Lett       Date:  2013-04-04       Impact factor: 2.823

8.  Histone acetyltransferase Rtt109 is required for Candida albicans pathogenesis.

Authors:  Jessica Lopes da Rosa; Victor L Boyartchuk; Lihua Julie Zhu; Paul D Kaufman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

9.  Serological profiling of a Candida albicans protein microarray reveals permanent host-pathogen interplay and stage-specific responses during candidemia.

Authors:  A Brian Mochon; Ye Jin; Jin Ye; Matthew A Kayala; John R Wingard; Cornelius J Clancy; M Hong Nguyen; Philip Felgner; Pierre Baldi; Haoping Liu
Journal:  PLoS Pathog       Date:  2010-03-26       Impact factor: 6.823

10.  C2'-OH of amphotericin B plays an important role in binding the primary sterol of human cells but not yeast cells.

Authors:  Brandon C Wilcock; Matthew M Endo; Brice E Uno; Martin D Burke
Journal:  J Am Chem Soc       Date:  2013-06-03       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.